A verified TB-500 certificate of analysis ensures high-purity, lot-traced research compounds for rigorous in vitro and preclinical investigation. PX1 Research provides comprehensive third-party testing reports—including RP-HPLC purity profiles, mass spectrometry verification, and endotoxin assays—for every lot of laboratory-grade peptides.
A verified TB-500 certificate of analysis ensures high-purity, lot-traced research compounds for rigorous in vitro and preclinical investigation. PX1 Research provides comprehensive third-party testing reports—including RP-HPLC purity profiles, mass spectrometry verification, and endotoxin assays—for every lot of laboratory-grade peptides.
A authentic tb-500 certificate of analysis serves as the primary document of quality assurance for laboratory scientists and procurement teams evaluating peptide integrity. TB-500 is a synthetic derivative representing the active functional domain—specifically the acylated N-terminal hexapeptide fragment LKKTETQ—of the naturally occurring actin-sequestering protein Thymosin Beta-4. Because minor impurities or synthesis byproducts can significantly alter cellular responses during *in vitro* assays and animal models, confirming analytical identity and purity via a lot-specific COA is an indispensable requirement.
A compliant certificate of analysis must clearly display raw data and peak integration profiles obtained from independent, ISO/IEC 17025-accredited analytical laboratories. Essential parameters detailed on a standard report include the compound's chemical name, CAS registry number, molecular formula, theoretical exact mass, measured molecular weight, peak purity percentage established via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), and quantitative bacterial endotoxin levels. PX1 Research mandates that every batch of research peptides undergoes rigorous multi-instrument verification prior to laboratory distribution.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the golden benchmark for determining the chemical purity of synthetic peptides. During RP-HPLC testing, a sample of TB-500 is solubilized and injected onto a non-polar stationary phase column (typically C18 silica). A mobile phase gradient consisting of water, acetonitrile, and an ion-pairing modifier such as trifluoroacetic acid (TFA) is eluted through the column. Individual chemical species segregate based on their hydrophobic interactions, producing a distinct chromatogram detected at UV wavelengths (typically 214 nm or 220 nm, corresponding to the peptide backbone absorption peak).
The resulting chromatogram provides a quantifiable visual profile where peak area integration determines the relative concentration of the target peptide relative to baseline noise and synthesis artifacts. Laboratories seeking standardized reagents should look for HPLC peak integrations demonstrating no less than 98.0% purity. In complete tb-500 purity testing documentation, truncated sequence variants, deletion peptides, or residual protecting groups appear as distinct minor peaks; high-purity COAs confirm their absence or strict minimization below established tolerance thresholds.
While RP-HPLC establishes chemical purity, it cannot independently confirm the precise molecular structure or amino acid sequence of a peptide fragment. Consequently, a comprehensive tb-500 certificate of analysis must incorporate Mass Spectrometry (MS)—typically utilizing Electrospray Ionization (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry.
Mass spectrometry measures the mass-to-charge ratio (m/z) of the ionized peptide sample. For synthetic TB-500 (N-acetyl-LKKTETQ, C38H68N10O14, theoretical monoisotopic mass ~888.98 g/mol), the mass spectrum must reveal a primary peak corresponding exactly to the calculated molecular weight or its predictable adduct states (e.g., [M+H]+ or [M+2H]2+). Any significant deviation in observed molecular mass indicates amino acid substitution, incomplete deprotection, or improper acylation during solid-phase peptide synthesis (SPPS). Researchers can cross-examine published analytical parameters within the PX1 research hub to cross-reference expected spectral properties across various sequence variants.
For preclinical research applications—particularly cell culture assays, organoid modeling, or *in vivo* animal studies—the presence of bacterial endotoxins poses a severe confounding variable. Pyrogenic lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls can trigger non-specific inflammatory signaling cascades, masking or distorting the biological mechanisms under investigation.
PX1 Research enforces strict endotoxin screening utilizing standardized Limulus Amebocyte Lysate (LAL) chromogenic assays. A compliant COA specifies endotoxin concentrations expressed in Endotoxin Units per milligram (EU/mg). Standard research-grade specifications require endotoxin levels to remain well below 0.1 EU/mg, preventing cell toxicity or unconditioned immune activation during biological assays. Every production run undergoes validated endotoxin verification within GMP-compliant, ISO 17025-certified laboratory testing environments.
In cell biology and biochemistry literature, TB-500 is primarily investigated as a key regulator of actin cytoskeleton dynamics. Preclinical studies suggest that the core LKKTETQ peptide sequence mimics the active binding site of native Thymosin Beta-4, sequestering monomeric G-actin to maintain a mobile intracellular actin pool necessary for rapid structural remodeling.
Experimental data indicate that this mechanism plays a vital role in promoting endothelial cell migration, stimulating focal adhesion formation, and enhancing local blood-vessel formation (angiogenesis) during tissue modeling studies. Furthermore, *in vitro* assays demonstrate that TB-500 upregulation correlates with enhanced cell motility, extracellular matrix remodeling, and increased flexibility during soft-tissue and muscle-fiber recovery models. Researchers studying cellular repair cascades frequently cross-reference these biological actions when designing assays involving soft tissue repair or cellular migration models.
When designing tissue regeneration and cell migration experiments, researchers frequently evaluate multiple signaling peptides within the same investigational class. Comparing their structural profiles on analytical certificates reveals distinct molecular properties. For example, full-length thymosin-beta-4 consists of a 43-amino acid polypeptide chain (~4.9 kDa), requiring extensive chromatographic separation compared to the concise synthetic hexapeptide structure of tb-500 (~889 Da). Both target actin sequestration pathways, yet possess distinct physical stability profiles in solution.
In contrast, bpc-157 (Pentadecapeptide BPC 157) represents a completely distinct sequence class derived from human gastric juice proteins, operating through nitric oxide synthesis modulation, VEGFR2 activation, and focal adhesion kinase pathways rather than direct G-actin binding. Evaluating detailed COAs for each compound enables investigators to select reagents with validated purity and accurate molecular weights, ensuring reproducibility across comparative bpc-157 vs tb-500 mechanisms studies or multi-peptide preclinical frameworks such as those pairing ghrp-6 in metabolic or repair pathways.
Lyophilized research peptides require precise physical handling to maintain structural integrity and avoid enzymatic degradation prior to experimental application. Upon receipt, lyophilized TB-500 vials should be stored in a controlled freezer environment at -20°C or -80°C to preserve long-term stability.
When preparing samples for *in vitro* or analytical procedures, reconstitution must be conducted under sterile laminar flow hoods using suitable laboratory solvents such as sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4). Researchers should avoid vigorous vortexing, which can induce mechanical shear stress and peptide denaturation; gentle agitation or passive dissolution is recommended. For precise volumetric calculations and molar dilution protocols, laboratory technicians can utilize the peptide reconstitution calculator to ensure exact concentrations during experimental setup.
A certificate of analysis is only as reliable as the laboratory generating the data. PX1 Research exclusively partners with independent, domestic third-party testing facilities that hold formal ISO/IEC 17025 accreditation. This accreditation verifies that the analytical laboratory adheres to rigorous calibration standards, standardized equipment maintenance schedules, and validated analytical methodologies.
Every batch of TB-500 is assigned a unique lot number that directly corresponds to its public certificate of analysis. Procurement officers and principal investigators can independently verify lot authenticity, ensuring complete traceability from raw material synthesis through final lyophilization and packaging. This transparent analytical architecture mitigates batch-to-batch variability and protects experimental integrity.
PX1 Research operates an advanced domestic supply chain engineered specifically for academic institutions, biotechnology firms, and contract research organizations (CROs). All peptides are manufactured under strict state-of-the-art procedures in USA-based, GMP-compliant facilities to eliminate international supply chain vulnerabilities and degradation during transit.
Orders are fulfilled directly from centralized warehouse facilities in California and Arizona, providing guaranteed same-day shipping for orders placed Monday through Friday. Laboratories requiring high-volume supplies or specialized custom synthesis batches can utilize our dedicated wholesale lab account portal to access volume pricing, bulk lot documentation, and dedicated technical account support.
What is a tb-500 certificate of analysis?
A tb-500 certificate of analysis (COA) is an official analytical document provided by an independent testing laboratory that details the identity, chemical purity, molecular mass, and endotoxin levels of a specific lot of synthetic TB-500 research peptide.
How do I read an HPLC chromatogram on a TB-500 COA?
An HPLC chromatogram displays time on the X-axis (retention time) and UV absorbance response on the Y-axis. The primary peak represents intact TB-500. The area under the primary peak divided by the total integrated peak area yields the peptide purity percentage, which should exceed 98.0%.
What is the minimum acceptable purity percentage on a TB-500 certificate of analysis?
For rigorous preclinical research and in vitro cell culture assays, a minimum purity of 98.0% verified via RP-HPLC is required to prevent confounding results caused by synthesis byproducts or truncated fragments.
Why is mass spectrometry (MS) critical for verifying synthetic TB-500?
Mass spectrometry confirms the exact molecular mass and chemical identity of TB-500 (theoretical monoisotopic mass ~888.98 g/mol). HPLC measures relative purity, but MS verifies that the peptide sequence matches the correct molecular structure.
What endotoxin threshold is acceptable for TB-500 in preclinical laboratory models?
A high-quality research COA should specify endotoxin levels below 0.1 EU/mg (measured via LAL assay) to ensure the compound does not induce non-specific inflammatory responses in cellular assays or animal models.
How does TB-500 differ structurally from full-length Thymosin Beta-4 on analytical reports?
TB-500 is a synthetic short-chain hexapeptide fragment (N-acetyl-LKKTETQ, ~889 Da) representing the active binding region of native Thymosin Beta-4, whereas full-length Thymosin Beta-4 is a 43-amino acid protein with a molecular weight of approximately 4.9 kDa.
How should lyophilized TB-500 be stored upon receipt in the laboratory?
Lyophilized TB-500 vials should be stored at -20°C or -80°C in a dry environment away from light. Reconstituted solutions should be aliquoted and maintained at -20°C or kept at 2°C to 8°C for short-term experimental use.
What solvent should be used for reconstituting TB-500 for in vitro assays?
TB-500 is typically reconstituted using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) under aseptic conditions in a laminar flow hood.
Can I request lot-specific COAs for bulk or wholesale laboratory orders?
Yes. PX1 Research provides batch-specific, independent third-party COAs for all individual vials and bulk wholesale orders through our dedicated wholesale support system.
How quickly are PX1 Research TB-500 orders processed and shipped?
All orders placed Monday through Friday are processed with guaranteed same-day shipping from our dual fulfillment centers located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.